ProductDetails

Overview Features AI-Decision
A medical professional taking guided pictures of a patient with DermaGraphix assistance

Template-GuidedBody Map Photography

DermaGraphix capture templates control IntelliStudio camera settings and guide patient poses for consistent whole body photography with minimal staff training.

A medical professional taking pictures of a patient

Dermoscopic ImagesEasily Tagged to Body Map

All dermoscopic images associated with a lesion are linked to an automatically-generated unique number and tagged to the body map for efficient exams and accurate follow-ups. (Wireless tagging or USB tethering with compatible dermatoscopes.)

Request a Quote

ProductFeatures

Markerless Tracking*

allows clinicians to more easily review changes between timepoints

Smart Automation

ensures standardization and reproducibility

Structured Follow-up

yields efficiency and repeatability

Image Dashboard

optimizes review and assessment

Dermoscopic images organized by DermaGraphix for efficient review

Faster Reviews WithBetter Organized Data

DermaGraphix Dashboard organizes dermoscopy images for optimal review and assessment, with same lesion in a single column and same visit in a single row.

Lesion changes being monitored within DermaGraphix

Dermoscopic ImagesEasy Surveillance

All photos, notes and attributes associated with a lesion are available for instant review and comparison. Full screen comparison between time points includes all image capture and lighting modalities.

Markerless Tracking*Comparisons

Allows comparison of skin surfaces from two body maps allowing for efficient clinical review.

A printable lesion report generated by DermaGraphix

Printable Lesion Reports

Personalized reports with provision for clinician to document 3-point, 7-point, and ABCD rule assessment results, clinical notes for billing, and patient referral fulfillment.

Best-in-class AI-decision support for skin cancer with the most complete system

Lesion Visualizer

MDR approved clinical decision support for smarter lesion assessment.

CE Marked | EU MDR Class IIa

DEXI®

The leading dermoscopy-based medical device where AI supports your skin cancer assessment.

CE Marked | EU MDR Class IIb

*Available in the EU. In all other countries, DEXI and Lesion Visualizer is for research use only.

What OurExperts Say...

*Available in the EU. In all other countries, DEXI and Lesion Visualizer is for research use only.

*DEXI & Lesion Visualizer are available within the DermaGraphix platform.